IL6 and Cirrhosis: Future studies are required to study gene/protein expression analysis of inflammatory biomarkers such as interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α), transforming growth factor-beta (TGF-β), and monocyte chemoattractant protein 1 (MCP-1) to understand the mechanism of action of cirrhosis reversal by vitexin in detail.